Bariatric Surgery Candidate clinical trials at UCSF
1 research study open to eligible people
open to eligible people ages 25 years and up
Bariatric surgery leads to bone loss and increases fracture risk. This study evaluates whether denosumab can prevent the high-turnover bone loss that occurs after Roux-en-Y Gastric Bypass (RYGB) and sleeve gastrectomy (SG) surgery.
San Francisco, California and other locations